Scott T. Rottinghaus - Aug 8, 2023 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Chief Medical Officer
Signature
/s/ Matthew Kowalsky as attorney-in-fact
Stock symbol
ENTA
Transactions as of
Aug 8, 2023
Transactions value $
-$43,939
Form type
4
Date filed
8/9/2024, 05:24 PM
Previous filing
Nov 28, 2022
Next filing
Nov 22, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Tax liability -$25.3K -1.47K -5.43% $17.23 25.5K Aug 8, 2023 Direct F1, F2
transaction ENTA Common Stock Tax liability -$18.7K -1.47K -7.24% $12.73 18.8K Aug 8, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.
F2 Such amount excludes securities acquired or disposed of subsequent to August 8, 2023.

Remarks:

Exhibit 24 Power of Attorney filed herewith.